Zimmer Biomet (ZBH) PT Raised to $116 at UBS
Tweet
Share
E-mailGet Alerts ZBH Hot Sheet
Price: $87.09 -1%
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
18 Buy, 25 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
UBS analyst Danielle Antalffy raised the price target on Zimmer Biomet (NYSE: ZBH) to $116.00 (from $112.00) while maintaining a Sell rating.
You May Also Be Interested In
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Definium Therapeutics Inc (DFTX) PT Raised to $52 at Leerink
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
